Latest news with #VSee
Globe and Mail
25-06-2025
- Health
- Globe and Mail
VSee Health ($VSEE): AI Telehealth Powerhouse Tapped for NIH Stroke Study as It Redefines the $787B Digital Healthcare Market
With Backing from NASA, the U.S. Government, and a $328M Stroke Rehab Opportunity on Deck, VSee Is Quietly Becoming a Major Force in Next-Gen Healthcare Imagine a world where stroke recovery happens from the comfort of home. A world where AI-powered nursing robots reduce hospital costs, and maternal care reaches the most remote corners of the world with just a mobile signal. That's not a futuristic dream—it's the reality VSee Health (Nasdaq: VSEE) is building today. Already trusted by NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and even the entire nation of Qatar, VSEE is quietly positioning itself as a backbone for digital healthcare infrastructure globally. And now, it's been chosen to support a Phase 3 NIH-funded clinical study on stroke rehabilitation, unlocking a $328 million global market and sending a strong signal to investors: VSEE is a telehealth leader with real-world traction, high-value contracts, and breakout potential. $328M Stroke Rehab Market Now in VSee's Sights On June 23, VSee announced it has been selected to power a UCLA-led, NIH-funded Phase 3 clinical trial for stroke recovery telerehabilitation. The study will include 202 patients across 29 hospitals, testing whether home-based, gamified rehabilitation using VSee's platform can significantly improve arm mobility in stroke survivors—while slashing costs tied to travel, caregivers, and hospital readmissions. 'This is the kind of national, evidence-backed validation investors dream about,' said one industry analyst. If successful, the study could trigger Medicare and private payer reimbursements, opening doors to widespread commercialization in the stroke recovery market—and beyond. VSee's telerehab tools could soon be applied to other high-cost areas like spinal cord injuries, multiple sclerosis, and traumatic brain injuries. From the Philippines to U.S. Hospitals: Scaling Globally with AI VSEE isn't just growing—it's making impact globally. On May 16, the company launched Project MAMA in the remote Philippines, using AI chatbots, portable diagnostic tools, and tele-OB-GYN services to combat maternal mortality in underserved areas. The pilot went live in just four days, demonstrating how fast VSee can deploy critical healthcare infrastructure. Back in the U.S., the company recently unveiled a Telenursing Robotics platform aimed at cutting hospital nursing costs by 3–5%, addressing a $300 billion labor challenge in American healthcare. The solution automates routine nursing tasks, improving patient throughput while relieving overwhelmed hospital staff. Modular, No-Code, "Lego-Like" AI Platform That Scales Fast VSee's biggest edge? Its modular, no-code/low-code platform that allows hospitals and governments to build customized digital health ecosystems without hiring a single engineer. Described as 'Lego-like digital health building blocks,' VSee's technology integrates with major EHR systems (like Oracle Cerner), supports multilingual communication in 240+ languages (via LanguageLine), and powers over 1.5 million HIPAA-compliant video visits per month. This unmatched flexibility is why VSee keeps winning big: $2M hospital contract for neurocritical care robotics. $560K deal with a major oncology network. $444K government mental health platform contract. $6M+ government telehealth deployment agreement —just in its first year. EHR integration with DaVita's top kidney care provider to improve telehealth call success rates by 88%. Telepresence Robots, Unified Health Records & More In addition to NIH trials and hospital contracts, VSee is collaborating with Ava Robotics to bring intelligent telepresence robots to ICUs, allowing doctors to remotely round on patients with real-time video and data. Meanwhile, its partnership with AbundaBox launched AbundaLife™, a revolutionary platform to unify patient medical records into one secure profile—solving the $30B+ fragmentation problem in healthcare data. Built for the Future of Healthcare Whether it's autonomous robotics, remote maternal care, gamified rehab, or multilingual telehealth, VSee isn't reacting to the digital health future—it's building it. With a platform already trusted by the U.S. government, NASA, and a growing list of major healthcare providers, VSee is now positioned to lead in: Investor Takeaway: A Pure-Play AI Telehealth Growth Story VSee Health ($VSEE) stands at the crossroads of AI, telehealth, robotics, and healthcare accessibility—all major investment themes for 2025 and beyond. With clinical validation from the NIH, a growing roster of contracts and partnerships, and a platform that delivers at scale, VSee is more than a telehealth company—it's a digital health infrastructure play. And with the global digital health market projected to hit $787 billion, VSee's current valuation could represent just the beginning. Website: Disclosure listed on the CorporateAds website Media Contact Company Name: Vsee Health, Inc. Contact Person: Anne Chang Email: Send Email Phone: 626-513-1824 Address: One Gateway Center Suite 507 300 Washington St. City: Newton State: Massachusetts Country: United States Website:
Business Wire
23-06-2025
- Business
- Business Wire
VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial
SAN JOSE, Calif.--(BUSINESS WIRE)-- VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke survivors while reducing costs like transportation, caregiver burdens, and hospital readmissions. This Phase 3 VSee as the go-to platform for the next wave of value-based virtual care that improves outcomes while reducing costs. The proven efficacy of Phase 3 trials opens doors for Medicare and private payer reimbursement and opportunities in the $328M global stroke rehab marke t, where telehealth could disrupt traditional physical therapy with better adherence and lower costs. Success also paves the way for gamified telerehabilitation in other areas, e.g. multiple sclerosis, spinal cord injury, and traumatic brain injury rehab. Professor of neurology at UCLA and a co-principal investigator, Dr. Steven Cramer, MD affirms, 'Reaching Phase 3 in a clinical trial of this scale is a hard-won milestone that has been twelve years in the making—one that wouldn't have been possible without the right partners. VSee Health's HIPAA-compliant platform has been instrumental in ensuring secure, seamless delivery of our interventions—critical for maintaining compliance and engagement in a large-scale trial like this.' Dr. Milton Chen, PhD, Co-CEO of VSee Health adds, 'We're grateful and proud of VSee's role in two of the only nationwide U.S. stroke tele-rehab trials. This Phase 3 trial validates telehealth as a scalable, cost-effective model for neurorehabilitation, and positions VSee as the go-to platform for the next wave of value-based virtual care that improves outcomes while reducing costs.' This trial further solidifies VSee's position as a key player in the telerehab market, building on VSee's prior role in Phase 1 and Phase 2 of this neurology study. Enrollment for the clinical trial begins Q3 2025, with the study combining independent and remote therapist-supervised games and exercises via VSee to overcome barriers like limited access to physical therapy clinics and poor patient motivation. Forward-Looking Statements This press release includes 'forward-looking statements' within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as 'believes,' 'expects,' 'plans,' 'may,' 'should,' 'will,' 'seeks,' or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company's ability to regain compliance with Nasdaq's listing rules within the required timeframe. These statements are based on current expectations on the date of this press release and involve a number of risks and uncertainties that may cause actual results to differ significantly, including those risks set forth in the Company's most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-K and other SEC-filed documents. Such filing copies are available on the SEC's website The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to rely on forward-looking statements. About VSee Health Trusted by top health systems and researchers, VSee Health provides a highly customizable and HIPAA-compliant digital health platform and services to effectively deliver integrated healthcare from a distance—bridging gaps in access, engagement, and data security. Visit
Business Wire
16-05-2025
- Health
- Business Wire
VSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote Philippines
SAN JOSE, Calif.--(BUSINESS WIRE)-- VSee Health, Inc. (Nasdaq: VSEE), a leader in digital health solutions, customized virtual health workflow integration, and real-time health data analytics, announces the launch of Project MAMA (Mom's AI for Maternity Aid), an innovative telehealth initiative to reduce high maternal mortality rates in rural, isolated Philippines communities of Zamboanga Sibugay. This program demonstrates impact by delivering quality prenatal care to mothers who've previously never gotten an ultrasound or been seen by an OB-GYN Share Working with maternal care physicians and specialists from Stanford University and Ateneo de Zamboanga University, VSee's technology bridges the gap in prenatal care access, enabling women in underserved areas to receive remote OB-GYN consultations via its comprehensive telehealth platform. The solution features AI chatbots responding in local languages, portable diagnostic devices (e.g. ultrasounds) and electronic health records (EHRs) — all operational within four days of deployment. "Project MAMA exemplifies our commitment to addressing global healthcare disparities through innovative technology," said Dr. Milton Chen, PhD, co-CEO of VSee Health. "This program demonstrates impact by delivering quality prenatal care to mothers who've previously never gotten an ultrasound or been seen by an OB-GYN. We also plan to explore more ways to leverage AI — analyzing patient data trends for early detection of maternal mortality risk." The pilot program represents VSee's broader vision of bringing accessible healthcare to underserved populations worldwide through adaptable, AI-enhanced telehealth solutions. Forward-Looking Statements This press release includes 'forward-looking statements' within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as 'believes,' 'expects, 'intends,' 'plans,' 'estimates,' 'assumes,' 'may,' 'should,' 'will,' 'seeks,' or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company's ability to regain compliance with Nasdaq's listing rules within the required timeframe. These statements are based on current expectations on the date of this press release and involve a number of risks and uncertainties that may cause actual results to differ significantly, including those risks set forth in the Company's most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q and other documents filed with the SEC. Copies of such filings are available on the SEC's website at The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements. About VSee Health VSee Health (Nasdaq: VSEE) is a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by 1,000+ clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSee Health provides foundational infrastructure for digital healthcare and delivers turnkey solutions to optimize healthcare operations while increasing billable patient visits and provider efficiency. Visit
Yahoo
16-05-2025
- Business
- Yahoo
VSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote Philippines
SAN JOSE, Calif., May 16, 2025--(BUSINESS WIRE)--VSee Health, Inc. (Nasdaq: VSEE), a leader in digital health solutions, customized virtual health workflow integration, and real-time health data analytics, announces the launch of Project MAMA (Mom's AI for Maternity Aid), an innovative telehealth initiative to reduce high maternal mortality rates in rural, isolated Philippines communities of Zamboanga Sibugay. Working with maternal care physicians and specialists from Stanford University and Ateneo de Zamboanga University, VSee's technology bridges the gap in prenatal care access, enabling women in underserved areas to receive remote OB-GYN consultations via its comprehensive telehealth platform. The solution features AI chatbots responding in local languages, portable diagnostic devices (e.g. ultrasounds) and electronic health records (EHRs) — all operational within four days of deployment. "Project MAMA exemplifies our commitment to addressing global healthcare disparities through innovative technology," said Dr. Milton Chen, PhD, co-CEO of VSee Health. "This program demonstrates impact by delivering quality prenatal care to mothers who've previously never gotten an ultrasound or been seen by an OB-GYN. We also plan to explore more ways to leverage AI — analyzing patient data trends for early detection of maternal mortality risk." The pilot program represents VSee's broader vision of bringing accessible healthcare to underserved populations worldwide through adaptable, AI-enhanced telehealth solutions. Forward-Looking Statements This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as "believes," "expects, "intends," "plans," "estimates," "assumes," "may," "should," "will," "seeks," or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company's ability to regain compliance with Nasdaq's listing rules within the required timeframe. These statements are based on current expectations on the date of this press release and involve a number of risks and uncertainties that may cause actual results to differ significantly, including those risks set forth in the Company's most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q and other documents filed with the SEC. Copies of such filings are available on the SEC's website at The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements. About VSee Health VSee Health (Nasdaq: VSEE) is a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by 1,000+ clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSee Health provides foundational infrastructure for digital healthcare and delivers turnkey solutions to optimize healthcare operations while increasing billable patient visits and provider efficiency. Visit View source version on Contacts VSee HealthAnne Changmedia@ Investor Contact:Dave GentryRedChip Companies1-407-644-4256VSEE@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
16-05-2025
- Health
- Associated Press
VSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote Philippines
SAN JOSE, Calif.--(BUSINESS WIRE)--May 16, 2025-- VSee Health, Inc. (Nasdaq: VSEE), a leader in digital health solutions, customized virtual health workflow integration, and real-time health data analytics, announces the launch of Project MAMA (Mom's AI for Maternity Aid), an innovative telehealth initiative to reduce high maternal mortality rates in rural, isolated Philippines communities of Zamboanga Sibugay. This press release features multimedia. View the full release here: Local clinic staff performs a prenatal checkup using the VSee telemedicine kit and digital health platform. Working with maternal care physicians and specialists from Stanford University and Ateneo de Zamboanga University, VSee's technology bridges the gap in prenatal care access, enabling women in underserved areas to receive remote OB-GYN consultations via its comprehensive telehealth platform. The solution features AI chatbots responding in local languages, portable diagnostic devices (e.g. ultrasounds) and electronic health records (EHRs) — all operational within four days of deployment. 'Project MAMA exemplifies our commitment to addressing global healthcare disparities through innovative technology,' said Dr. Milton Chen, PhD, co-CEO of VSee Health. 'This program demonstrates impact by delivering quality prenatal care to mothers who've previously never gotten an ultrasound or been seen by an OB-GYN. We also plan to explore more ways to leverage AI — analyzing patient data trends for early detection of maternal mortality risk.' The pilot program represents VSee's broader vision of bringing accessible healthcare to underserved populations worldwide through adaptable, AI-enhanced telehealth solutions. Forward-Looking Statements This press release includes 'forward-looking statements' within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as 'believes,' 'expects, 'intends,' 'plans,' 'estimates,' 'assumes,' 'may,' 'should,' 'will,' 'seeks,' or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company's ability to regain compliance with Nasdaq's listing rules within the required timeframe. These statements are based on current expectations on the date of this press release and involve a number of risks and uncertainties that may cause actual results to differ significantly, including those risks set forth in the Company's most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q and other documents filed with the SEC. Copies of such filings are available on the SEC's website The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements. About VSee Health VSee Health (Nasdaq: VSEE) is a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by 1,000+ clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSee Health provides foundational infrastructure for digital healthcare and delivers turnkey solutions to optimize healthcare operations while increasing billable patient visits and provider efficiency. Visit View source version on CONTACT: VSee Health Anne Chang [email protected] Contact: Dave Gentry RedChip Companies 1-407-644-4256 [email protected] KEYWORD: NORTH AMERICA UNITED STATES ASIA PACIFIC SOUTHEAST ASIA PHILIPPINES CALIFORNIA NEW YORK INDUSTRY KEYWORD: TECHNOLOGY PUBLIC POLICY/GOVERNMENT HEALTHCARE REFORM TELEMEDICINE/VIRTUAL MEDICINE SOFTWARE HEALTH GENERAL HEALTH DATA MANAGEMENT ARTIFICIAL INTELLIGENCE SOURCE: VSee Health, Inc. Copyright Business Wire 2025. PUB: 05/16/2025 08:23 AM/DISC: 05/16/2025 08:22 AM
